Yoshitaka Yagi
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model.
Journal: Molecular cancer research : MCR
Published: April 03, 2018
Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer.
Journal: Oncotarget
Published: December 22, 2016
Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.
Journal: Scientific reports
Published: November 24, 2016
Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer.
Journal: Molecular and clinical oncology
Published: September 25, 2015
Response to chemotherapy with carboplatin plus albumin-bound paclitaxel in a patient with lymphoepithelioma-like thymic carcinoma: A case report.
Journal: Molecular and clinical oncology
Published: August 27, 2015
Successful treatment with carboplatin and nanoparticle albumin-bound paclitaxel in a patient with pulmonary spindle cell carcinoma.
Journal: Respiratory medicine case reports
Published: August 04, 2015
Long survival of a small-cell lung cancer patient who received maintenance chemotherapy with irinotecan.
Journal: Case reports in oncology
Published: December 19, 2013
High-dose crizotinib for brain metastases refractory to standard-dose crizotinib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 16, 2013
Effect of liver toxicity on clinical outcome of patients with non-small-cell lung cancer treated with pemetrexed.
Journal: Molecular and clinical oncology
Published: July 01, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026